Drug Repurposing for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer which presents a high rate of relapse, metastasis, and mortality. Nowadays, the absence of approved specific targeted therapies to eradicate TNBC remains one of the main challenges in clinical practice. Drug discovery...

Descripción completa

Detalles Bibliográficos
Autores principales: Ávalos-Moreno, Marta, López-Tejada, Araceli, Blaya-Cánovas, Jose L., Cara-Lupiañez, Francisca E., González-González, Adrián, Lorente, Jose A., Sánchez-Rovira, Pedro, Granados-Principal, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711505/
https://www.ncbi.nlm.nih.gov/pubmed/33138097
http://dx.doi.org/10.3390/jpm10040200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711505/
https://www.ncbi.nlm.nih.gov/pubmed/33138097
http://dx.doi.org/10.3390/jpm10040200

Ejemplares similares